Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome
- PMID: 8523629
- DOI: 10.1177/0148607195019004296
Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome
Abstract
Background: Massive loss of intestinal surface area results in the short bowel syndrome characterized by malabsorption of fluid, electrolytes, and other nutrients. Although the remaining bowel undergoes morphological and functional adaptation, often these changes are inadequate to support the individual by enteral feedings, and parenteral nutrition is required to prevent dehydration, electrolyte disturbances, and malnutrition. Substances such as growth hormone, glutamine, and fiber exert bowel-specific trophic effects and either directly or indirectly influence nutrient absorption. This study was undertaken to determine whether the co-administration of exogenous growth hormone, supplemental glutamine, and a modified fiber-containing diet could enhance nutrient absorption in patients who had undergone massive intestinal resection.
Methods: Ten patients (5 men, 5 women, aged 43 +/- 4 years) with short bowel syndrome were studied 6 +/- 1 years after surgical resection. All patients were admitted to the Clinical Research Center for a 28-day period; the first week served as a control period when nutritional (enteral and parenteral) and medical management simulated usual home therapy. Thereafter, eight patients received exogenous growth hormone, supplemental glutamine, and a modified high-carbohydrate, high-fiber diet. Two patients were treated with the modified diet alone. The efficiency of net nutrient absorption (percent absorbed) for total calories, protein, fat, carbohydrate, water, and sodium was calculated from the measured nutrient intake and stool losses.
Results: Three weeks of treatment with growth hormone, glutamine, and a modified diet increased total caloric absorption from 60.1 +/- 6.0% to 74.3 +/- 5.0% (p < or = .003), protein absorption from 48.8 +/- 4.8% to 63.0 +/- 5.4% (p < or = .006), and carbohydrate absorption from 60.0 +/- 9.8% to 81.5 +/- 5.3% (p < or = .02). Fat absorption did not change (61.0 +/- 5.3% to 60.3 +/- 7.9%, p = NS). Water and sodium absorption increased from 45.7 +/- 6.7% to 65.0 +/- 7.3% (p < or = .002) and from 49.0 +/- 9.8% to 69.6 +/- 6.5% (p < or = .04), respectively. These absorptive changes resulted in a decrease in stool output (1,783 +/- 414 g/d control period vs 1,308 +/- 404 g/d third week of treatment, p < or = .05). Treatment with diet alone did not influence nutrient absorption or stool output.
Conclusions: The combined administration of growth hormone, glutamine, and a modified diet enhanced nutrient absorption from the remnant bowel after massive intestinal resection. These changes occurred in a group of patients that had previously failed to adapt to the provision of enteral nutrients. This therapy may offer an alternative to long-term dependence on total parenteral nutrition for patients with severe short bowel syndrome.
Similar articles
-
Effect of recombinant human growth hormone and enteral nutrition on short bowel syndrome.JPEN J Parenter Enteral Nutr. 2004 Nov-Dec;28(6):377-81. doi: 10.1177/0148607104028006377. JPEN J Parenter Enteral Nutr. 2004. PMID: 15568283
-
A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet.Ann Surg. 1995 Sep;222(3):243-54; discussion 254-5. doi: 10.1097/00000658-199509000-00003. Ann Surg. 1995. PMID: 7677455 Free PMC article. Clinical Trial.
-
The effectiveness of growth hormone, glutamine and a low-fat diet containing high-carbohydrate on the enhancement of the function of remnant intestine among patients with short bowel syndrome: a review of published trials.Clin Nutr. 2001 Jun;20(3):199-204. doi: 10.1054/clnu.2001.0423. Clin Nutr. 2001. PMID: 11407865 Review.
-
Clinical evidence of growth hormone, glutamine and a modified diet for short bowel syndrome: meta-analysis of clinical trials.Asia Pac J Clin Nutr. 2005;14(1):98-102. Asia Pac J Clin Nutr. 2005. PMID: 15734715
-
The nutritional management of short bowel syndrome.Nutr Clin Care. 2004 Jul-Sep;7(3):114-21. Nutr Clin Care. 2004. PMID: 15624543 Review.
Cited by
-
Influence of Growth Hormone and Glutamine on Intestinal Stem Cells: A Narrative Review.Nutrients. 2019 Aug 17;11(8):1941. doi: 10.3390/nu11081941. Nutrients. 2019. PMID: 31426533 Free PMC article. Review.
-
Effects of glutamine on intestinal permeability and bacterial translocation in TPN-rats with endotoxemia.World J Gastroenterol. 2003 Jun;9(6):1327-32. doi: 10.3748/wjg.v9.i6.1327. World J Gastroenterol. 2003. PMID: 12800250 Free PMC article.
-
Growth hormone for intestinal adaptation in patients with short bowel syndrome: systematic review and meta-analysis of randomized controlled trials.Curr Ther Res Clin Exp. 2011 Jun;72(3):109-19. doi: 10.1016/j.curtheres.2011.04.002. Curr Ther Res Clin Exp. 2011. PMID: 24648580 Free PMC article.
-
Intestinal Failure in a Neonate: A Surgical Emergency and Medical Catastrophe.Cureus. 2021 Aug 4;13(8):e16890. doi: 10.7759/cureus.16890. eCollection 2021 Aug. Cureus. 2021. PMID: 34513464 Free PMC article.
-
Intestinal failure: pathophysiological elements and clinical diseases.World J Gastroenterol. 2004 Apr 1;10(7):930-3. doi: 10.3748/wjg.v10.i7.930. World J Gastroenterol. 2004. PMID: 15052668 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous